Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
3.110
+0.040 (1.30%)
At close: Sep 12, 2025, 4:00 PM EDT
3.100
-0.010 (-0.32%)
After-hours: Sep 12, 2025, 7:48 PM EDT
Tivic Health Systems Employees
Tivic Health Systems had 7 employees as of December 31, 2024. The number of employees decreased by 2 or -22.22% compared to the previous year.
Employees
7
Change (1Y)
-2
Growth (1Y)
-22.22%
Revenue / Employee
$66,000
Profits / Employee
-$906,000
Market Cap
4.90M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7 | -2 | -22.22% |
| Dec 31, 2023 | 9 | -7 | -43.75% |
| Dec 31, 2022 | 16 | 9 | 128.57% |
| Dec 31, 2021 | 7 | -1 | -12.50% |
| Dec 31, 2020 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TIVC News
- 3 days ago - Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing - Business Wire
- 24 days ago - Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers - Business Wire
- 4 weeks ago - Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025 - Business Wire
- 4 weeks ago - Tivic Health Systems, Inc. (TIVC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Tivic Reports Second Quarter 2025 Financial Results - Business Wire
- 5 weeks ago - Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast - Business Wire
- 2 months ago - Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO - Business Wire
- 2 months ago - Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device - Business Wire